Artios Pharma

Artios is a leading independent DDR Company with a strong pipeline of novel cancer therapies in development with first-in-class & best-in-class potential.

Health and bio

Latest funding

$115M Series B+ · November 17, 2025

Source: fundraisingfox.com

Funding history ↓

Website: artios.com.

X: @artiospharma · 795 followers.

LinkedIn: artios-pharma-ltd.

Category: Health and bio.

Stage: Series B+.

Last round: Nov 17, 2025 · 360 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

X account@artiospharma · created Sep 7, 2016 (10 years old) · 795 followers

Website registeredMay 30, 2004 (22 years old)

Funding rounds

November 17, 2025
Series B+ · $115M
Source: fundraisingfox.com
September 7, 2016
X account created
May 30, 2004
Website created

Companies like Artios Pharma

CCamp4Series B+ · Jul 2022
LLassen Therapeutics$85M Series B+ · Jan 2024
MMemo Therapeutics$22M Series B+ · May 2024
NNormunity$75M Series B+ · Jan 2025
AARTBIO$132M Series B+ · Jul 2025
AAMPLY Discovery$1.75M Seed · May 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/artios-pharma (get a free API key).